SCHEMBL3503363

SCHEMBL3503363

CCCCOC(=O)CCCCCCCC(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.70
PAM P19021 2/20 0.63
GPR84 Q9NQS5 7/20 0.61
PPARG P37231 7/20 0.61
PPARD Q03181 7/20 0.61
PPARA Q07869 7/20 0.61
HDAC11 Q96DB2 5/20 0.61
TSHR P16473 4/20 0.61
PTPN1 P18031 3/20 0.61
ALDH1A1 P00352 2/20 0.61
TLR2 O60603 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
FABP4 P15090 2/20 0.61
KMT2A Q03164 2/20 0.61
SLC22A6 Q4U2R8 1/20 0.61
SLC22A8 Q8TCC7 1/20 0.61
MEN1 O00255 1/20 0.61
ESR1 P03372 1/20 0.61
ALOX15 P16050 1/20 0.61
PDE4A P27815 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6752108 1.00 DGKA (0.70) DGKAPAMGPR84PPARGPPARD
SCHEMBL31169670 1.00 DGKA (0.70) DGKAPAMGPR84PPARGPPARD
Sebacic Acid SCHEMBL18507849 1.00 DGKA (0.70) DGKAPAMGPR84PPARGPPARD
SCHEMBL3504758 1.00 DGKA (0.70) DGKAPAMGPR84PPARGPPARD
SCHEMBL3447290 1.00 DGKA (0.70) DGKAPAMGPR84PPARGPPARD
Dibutyl Sebacate SCHEMBL28088597 1.00 DGKA (0.70) DGKAPAMGPR84PPARGPPARD
SCHEMBL405153 1.00 DGKA (0.70) DGKAPAMGPR84PPARGPPARD
SCHEMBL3503295 1.00 DGKA (0.70) DGKAPAMGPR84PPARGPPARD
SCHEMBL2320735 1.00 DGKA (0.70) DGKAPAMGPR84PPARGPPARD
Stearic Acid SCHEMBL25281432 0.98 DGKA (0.74) DGKAPAMGPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117050792-A Diesel antiwear agent composition, preparation method thereof and diesel oil composition 中国石油化工股份有限公司 2023-11-14 CN claimed
CN-113462442-B Diesel antiwear agent composition, preparation method thereof and diesel oil composition 中国石油化工股份有限公司 2023-06-09 CN claimed
CN-113462442-A Diesel antiwear agent composition, preparation method thereof and diesel composition 中国石油化工股份有限公司 2021-10-01 CN claimed
US-20250197343-A1 CATIONIC LIPID TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-06-19 US disclosed
EP-4431489-A1 CATIONIC LIPID Takeda Pharmaceutical Company Limited (JP) 2024-09-18 EP disclosed
CN-118201905-A Cationic lipid 武田药品工业株式会社 2024-06-14 CN disclosed
CN-117050792-A Diesel antiwear agent composition, preparation method thereof and diesel oil composition 中国石油化工股份有限公司 2023-11-14 CN disclosed
US-11771697-B2 Small molecule degraders of polybromo-1 (PBRM1) DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-10-03 US disclosed
CN-113462442-B Diesel antiwear agent composition, preparation method thereof and diesel oil composition 中国石油化工股份有限公司 2023-06-09 CN disclosed
WO-2023085299-A1 CATIONIC LIPID 武田薬品工業株式会社 2023-05-19 WO disclosed
US-10844193-B2 Polymer compositions containing aliphatic esters as plasticisers NOVAMONT S.P.A. (IT) 2020-11-24 US disclosed
WO-2012085014-A1 VEGETABLE OIL DERIVATIVES AS EXTENDER OILS FOR ELASTOMER COMPOSITIONS. NOVAMONT S.P.A. (IT) 2012-06-28 WO disclosed
US-20100210745-A1 Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes REACTIVE SURFACES, LTD. (US) 2010-08-19 US disclosed
CN-1318462-C Acrylic resin, resin boards, transparent electrode boards for touch panels, touch panels, and processes for production of them MITSUBISHI RAYON CO (JP) 2007-05-30 CN disclosed
CN-1711293-A Acrylic resin, resin boards, transparent electrode boards for touch panels, touch panels, and processes for production of them MITSUBISHI RAYON CO (JP) 2005-12-21 CN disclosed
EP-1275688-B1 Foamable thermoplastic composition containing volatile blowing agent and expandable microspheres RIKEN TECHNOS CORP (JP) 2005-12-14 EP disclosed
US-6720361-B2 Foamable thermoplastic elastomer composition and method of producing the same RIKEN TECHNOS CORP. (JP) 2004-04-13 US disclosed
US-20030027880-A1 Foamable thermoplastic elastomer composition and method of producing the same RIKEN TECHNOS CORP. (JP) 2003-02-06 US disclosed
EP-1275688-A1 Foamable thermoplastic composition containing volatile blowing agent and expandable microspheres Riken Technos Corporation (JP) 2003-01-15 EP disclosed
US-4108671-A Dye-based inks with improved vehicles RICHLIN MILTON 1978-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11771697-B2 Small molecule degraders of polybromo-1 (PBRM1) PBRM1, SMARCC1, SMARCC2 DGKA 3640/4885PAM 3522/4885GPR84 2316/4885
US-20250197343-A1 CATIONIC LIPID NR1H3, NR1H2, NR1H4 DGKA 2506/4885PAM 2485/4885GPR84 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.